What was amended
The federal government registered the National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2026 (No. 4) on 30 April 2026. The amendment made changes to the existing National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Determination 2019 (PB 114 of 2019).
The source does not specify which prices or conditions were changed by this amendment.
Period in force
The amendment was in force from 30 April 2026 to 18 August 2026, when it was repealed.
Administering department and legislation
This determination is administered by the Department of Health, Disability and Ageing under the National Health Act 1953.
Key actions
- The full text of the amendment is available at https://www.legislation.gov.au/F2026L00487 for review of what pricing or conditions were changed during the 30 April to 18 August 2026 period.
- The current in-force version of the National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Determination 2019 (PB 114 of 2019) is available at legislation.gov.au to confirm what rules now apply, given this amendment has been repealed.
- The Department of Health, Disability and Ageing can be contacted to clarify obligations if this amendment affected PBS billing during that period. The source does not provide a contact address or phone number.
This is a plain-English summary for information only, not legal or compliance advice. Always check the official source or consult a qualified professional.